医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)

广告
第一作者: Thielen,N.
作者单位: Department of Haematology, Academic Medical Center, Amsterdam, Netherlands [1] Department of Haematology, Erasmus University Medical Center, Rotterdam, Netherlands [2] Department of Haematology, University Medical Center Groningen, Groningen, Netherlands [3] Department of Internal Medicine, Tergooiziekenhuizen, Hilversum, Netherlands [4] Department of Internal Medicine, Isala Klinieken, Zwolle, Netherlands [5] Department of Internal Medicine, Medisch Spectrum Twente, Enschede, Netherlands [6] Department of Haematology, University Medical Center Utrecht, Utrecht, Netherlands [7] HOVON Data Center, Erasmus University, Medical Center-Daniel Den Hoed, Rotterdam, Netherlands [8] Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium [9] Department of Haematology, VU University Medical Center, Amsterdam, Netherlands [10]
发布时间 2014-01-21
提交
  • 浏览0
European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷